Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

TEL AVIV, Israel, May 18, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company’s corporate credit rating to Investment Grade BBB-, with a stable outlook, from BB+. “This strong endorsement, our third upgrade from Fitch in less than two years, underscores... The post Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution appeared first on Montreal Gazette .

Original source: Montreal Gazette